Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response

SIMPLE SUMMARY: Local treatment for oligometastatic hormone-naive prostate cancer has been shown to be effective in phase II trials. As for the efficacy of targeted therapy for oligometastatic castration-resistant prostate cancer, the results of the phase trial are not yet available, but the number...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Soichiro, Takahara, Taro, Arita, Yuki, Toda, Kazuma, Kimura, Koichiro, Tanaka, Hajime, Yokoyama, Minato, Matsuoka, Yoh, Yoshimura, Ryoichi, Fujii, Yasuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833545/
https://www.ncbi.nlm.nih.gov/pubmed/35158833
http://dx.doi.org/10.3390/cancers14030567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833545/
https://www.ncbi.nlm.nih.gov/pubmed/35158833
http://dx.doi.org/10.3390/cancers14030567

Ejemplares similares